Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-15

Clinical Trial Update: Use of Cyclosporin A for the Treatment of Recurrent Miscarriage [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on using cyclosporin A to treat recurrent miscarriage in Phase 2/3, with no current status reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporin A (cyclosporine)

Snippet

Sponsor: Fudan University | Conditions: Miscarriage, Recurrent | Phase 2, Phase 3 | Status: UNKNOWN